Geron
GERN
C$1.88
Share price
-2.13%
Change (1 day)
-68.28%
Change (1 year)
Categories
Geron (GERN) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$0.40 Billion
According to Geron's latest financial reports the company's total liabilities are C$0.40 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Geron - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$0.44 B | 132.08% |
| 2023-12-31 | C$0.19 B | 29.17% |
| 2022-12-31 | C$0.15 B | 18.19% |
| 2021-12-31 | C$0.12 B | 66.56% |
| 2020-12-31 | C$76.22 M | 92.22% |
| 2019-12-31 | C$39.65 M | 285.52% |
| 2018-12-31 | C$10.28 M | 25.56% |
| 2017-12-31 | C$8.19 M | -22.53% |
| 2016-12-31 | C$10.57 M | 14.91% |
| 2015-12-31 | C$9.2 M | -81.03% |
| 2014-12-31 | C$48.5 M | 500.6% |
| 2013-12-31 | C$8.07 M | -42.59% |
| 2012-12-31 | C$14.06 M | 2.88% |
| 2011-12-31 | C$13.67 M | -66.51% |
| 2010-12-31 | C$40.83 M | 397.21% |
| 2009-12-31 | C$8.21 M | -13% |
| 2008-12-31 | C$9.43 M | -28.44% |
| 2007-12-31 | C$13.19 M | -75.83% |
| 2006-12-31 | C$54.58 M | 83.53% |
| 2005-12-31 | C$29.74 M | 152.41% |
| 2004-12-31 | C$11.78 M | -22.96% |
| 2003-12-31 | C$15.29 M | -68.69% |
| 2002-12-31 | C$48.84 M | -11.61% |
| 2001-12-31 | C$55.26 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | C$15.02 M | -96.26% | 🇺🇸 USA |
 Gilead Sciences GILD | C$50.97 B | 12,596.97% | 🇺🇸 USA |
 Bio-Techne TECH | C$0.85 B | 112.85% | 🇺🇸 USA |
 Incyte INCY | C$2.84 B | 607.59% | 🇺🇸 USA |
 CTI BioPharma
CTIC | C$0.18 B | -53.22% | 🇺🇸 USA |